In regard to Belkacémi and Vicini: High-dose brachytherapy using the MammoSite applicator "...Give me your hand, and let the subject see, to make them know"

Radiotherapy and Oncology

Volumn 82, Issue 3, 2007, Pages 355-356

  Niehoff, Peter ^a   Polgar, Csaba ^b   Kovács, György ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^c University Hospital S H   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; BREAST CANCER; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LETTER; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; SKIN TOXICITY; TELANGIECTASIA;

EID: 33847354625     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.10.008     Document Type: Letter

References (5)

1. Niehoff P., Polgár C.S., Kovács G., et al. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. Radiother Oncol 79 (2006) 316-320
2. Keisch M., Vicini F., Scroggins T., et al. Thirty-nine month results with the MammoSite brachytherapy applicator: details regarding cosmesis, toxicity and local control in partial breast irradiation. Proc Int J Radiat Oncol Biol 63 (2005) 10 [Abstract]
3. Van Limbergen E., Briot E., and Drijkoningen M. The skin-source measuring bridge. A method to avoid radiation teleangiectasia in the skin after interstitial implants for breast cancer. Int J Radiat Oncol Biol Phys 18 (1990) 1239-1244
4. Georg P., Georg D., and Van Limbergen E. The use of the source-skin distance measuring bridge indeed reduces skin teleangiectasia after interstitial boost in breast conserving therapy. Radiother Oncol 74 (2005) 323-330
5. Turesson I., and Notter G. The influence of fraction size in radiotherapy on the late normal tissue reaction (I + II). Int J Radiat Oncol Biol Phys 10 (1984) 593-606